059 A phase 3, randomised controlled trial comparing upadacitinib monotherapy to MTX monotherapy in MTX-naïve patients with active rheumatoid arthritis

Autor:	R van Vollenhoven, T Takeuchi, A L Pangan, A Friedman, M F Mohamed, S Chen, M Rischmueller, R Blanco, R M Xavier, V Strand
Rok vydání:	2019
Předmět:	medicine.medical_specialty Randomization business.industry medicine.disease law.invention Therapy naive Rheumatology Randomized controlled trial law Rheumatoid arthritis Internal medicine Medicine Pharmacology (medical) business
Zdroj:	Rheumatology. 58
ISSN:	1462-0332 1462-0324
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5321adf1f83c866bea80db9d94029bff https://doi.org/10.1093/rheumatology/kez106.058 Zobrazit plný text záznamu